The
Intellectual Property Owners Association (IPO) will offer a one-hour webinar
entitled: "Bio-Similars: The New Litigation Landscape" on Thursday,
April 22, 2010 beginning at 2:00 PM (EST).  The IPO webinar will provide an overview of the healthcare
reform measure that creates a regulatory pathway for generic versions of
large-molecule biotech drugs, which bears some resemblance to the longstanding
Hatch-Waxman regime that sets out how generic drug companies can challenge patents
held by pharmaceutical companies on small-molecule medicines.  The webinar will also examine the
differences between the two schemes, which are profound and will prove to be of
great importance in the years ahead. 
The speakers include Stuart Watt of Amgen Inc. and F. Dominic Cerrito of
Jones Day.  The registration fee
for the webinar is $100.  Those
interested in registering for the webinar, can do so here.